25 of the Best Pediatric Hematologist Oncologists Near Me

Dr. Ayala is the director of the Hemophilia and Bleeding Disorders Treatment Center at Johns Hopkins All Children's Hospital. She also is the hematology leader of the Young Women Bleeding Disorders/Menorrhagia Clinic, which focuses on a multidisciplinary approach to bleeding symptoms in girls and young women. Dr. Ayala also is involved in the Immune Dysregulation Clinic, which evaluates patients with autoimmune cytopenias in a multidisciplinary approach. Dr. Ayala joined the hospital in 2000. She was the chair of the Division of Hematology/Oncology between 2013-2017 and also served as interim director for the division between 2015-2016. Dr. Ayala's research experience includes multicenter national and international projects. Dr. Ayala received her medical degree from the University of Puerto Rico School of Medicine, her residency training at the San Juan City Hospital in Puerto Rico and her fellowship training at the Emory University School of Medicine Division of Pediatric Hematology/Oncology. Dr. Ayala is a member of the American Society of Pediatric Hematology/Oncology and the Hemophilia and Thrombosis Research Society. Her clinical expertise encompasses Hemophilia A, Blood Clots, Venous Thromboembolism (VTE), and Evans Syndrome. Dr. Ayala is board certified in American Board Of Pediatrics.

Dr. Dean is a hematologist-oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital staff in 2021. She was previously an attending physician with Pediatric Specialists of Virginia in the Center for Cancer and Blood Disorders and with Children’s National Hospital. Dr. Dean was the director of the Long-Term Follow-Up program at Pediatric Specialists of Virginia and Children’s National Hospital and director of the neuro-oncology program at Pediatric Specialists of Virginia. She was also a senior physician on the leukemia and lymphoma team. She was an assistant professor in the Department of Pediatrics at George Washington University School of Medicine and Health Science. Dr. Dean has published peer-reviewed articles, authored book chapters and lectured both nationally and internationally. Her clinical and research interests include the impact of physical activity on overall function, cardiac function and quality of life in leukemia and lymphoma patients. Dr. Dean earned her medical degree from Wake Forest University in Winston-Salem, North Carolina. She completed an internship and residency in pediatrics and a fellowship in pediatric hematology-oncology at St. Louis Children’s Hospital/Washington University in St. Louis. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1). Dr. Dean is board certified in American Board Of Pediatrics.

Lisa Maurer, MD, PhD, is a pediatric oncologist with an interest in pediatric leukemia and lymphoma. She is also a physician-scientist in the Lucas/ McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, Dr. Maurer's research focus is on the role of GRK2 in inhibition of the MALT1 proto-oncoprotein in lymphomagenesis.Dr. Maurer earned her medical degree from University of Wisconsin School of Medicine and Public Health and her PhD from the University of Wisconsin-Madison. She completed an internship and residency at the University of California San Francisco followed by a fellowship at UPMC Children’s Hospital of Pittsburgh.She is a member of the American Society of Pediatric Hematology Oncology and the AACR.View the full list of Dr. Maurer’s publications on PubMed. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Maurer is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Maurer is currently accepting new patients.

I enjoy travel and spending time with those I love. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Sickle Cell Disease, and Ewing Sarcoma. Dr. De La Maza is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. De La Maza is currently accepting new patients.

View the full list of Dr. Rapkin's publications on PubMed. His clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Rhabdoid Tumor, Non-Langerhans-Cell Histiocytosis, and Reticulohistiocytoma. Dr. Rapkin is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Rapkin is currently accepting new patients.

I enjoy playing cricket, watching sports and movies with friends and family. I am also interested in travelling around the world, playing piano and guitar. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Thalassemia, Hereditary Spherocytosis, and Ewing Sarcoma. Dr. Reddy is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Reddy is currently accepting new patients.

Felipe Bautista is a Pediatric Hematologist Oncology provider practicing medicine in Allentown, Pennsylvania. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Dr. Martínez-Torres specializes in pediatric hematology-oncology in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute in St. Petersburg, Florida. She joined the hospital staff in 2025. She earned her medical degree from Ponce Health Sciences University School of Medicine. She completed her pediatric residency at Saint Luke’s Medical Center/Ponce Health Sciences University. She then completed a fellowship in pediatric hematology and oncology at University of Miami/Jackson Health System. She speaks English and Spanish. Her clinical expertise encompasses Childhood Iron Deficiency Anemia. Dr. Martinez is board certified in American Board Of Pediatrics.

View the full list of Dr. Nolfi's publications on PubMed. Her clinical expertise encompasses Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), and Splenectomy. Dr. Nolfi is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Nolfi is currently accepting new patients.

View the full list of Dr. Bukowinski's publications on PubMed. His clinical expertise encompasses Desmoplastic Small Round Cell Tumor, Adult Soft Tissue Sarcoma, Leukemia, and Rhabdomyosarcoma. Dr. Bukowinski is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Bukowinski is currently accepting new patients.

Dr. Friedman is the King Fahd Professor of Oncology and Professor of Pediatrics at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. He received his M.D. from the Harvard Medical School (1983), did his pediatric internship and residency at Boston Children's Hospital (1983-86), and completed a fellowship in pediatric hematology-oncology at Johns Hopkins (1986-89). As a fellow, he did post-doctoral research at the Carnegie Institution Department of Embryology located on the Johns Hopkins Homewood campus. Dr. Friedman has served on the Pediatric Oncology faculty at Johns Hopkins since 1989. His laboratory focuses on investigation of normal and abnormal blood-cell formation. Dr. Friedman also cares for children with cancer, specializing in the treatment of leukemia. His clinical expertise encompasses Glioma, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Neuroblastoma. Dr. Friedman is board certified in American Board Of Pediatrics.

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology.He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital.Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia.Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals.View the full list of Dr. Kalpatthi’s publications on PubMed. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy. Dr. Kalpatthi is board certified in American Board Of Pediatrics. Dr. Kalpatthi is currently accepting new patients.

I spend my free time enjoying the outdoors. I am an avid hiker and camper, but I also greatly enjoy skiing and scuba diving. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Hepatoblastoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Davini is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Davini is currently accepting new patients.

Morgan Pines is a Pediatrics specialist and a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. His clinical expertise encompasses Hemoglobin E Disease, Thalassemia, Congenital Hemolytic Anemia, and Hemoglobinopathy. Dr. Pines is board certified in American Board Of Pediatrics.

Dr. Koldobskiy is an Assistant Professor of Pediatric Oncology and Pediatric Neuro-Oncology at the Sidney Kimmel Comprehensive Cancer Center. He received his B.S. and M.S. from Yale University and M.D./Ph.D. in the Medical Scientist Training Program at Johns Hopkins, conducting his thesis research with Dr. Solomon Snyder in Pharmacology and Molecular Sciences. He completed his Pediatrics residency training at Johns Hopkins and his Pediatric Hematology and Oncology fellowship training in the joint Johns Hopkins/National Institutes of Health program. He studies epigenetic variability in childhood cancer. His clinical expertise encompasses Leukemia, Glioma, Teratoma of the Mediastinum, and Acute Lymphoblastic Leukemia (ALL). Dr. Koldobskiy is board certified in American Board Of Pediatrics.

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. His clinical expertise encompasses Infantile Neutropenia, Rosai-Dorfman Disease, Pediatric Low-Grade Glioma (pLGG), and Leukemia. Dr. Maurer is board certified in American Board Of Pediatrics , American Board Of Pediatrics , and American Board Of Pediatrics. Dr. Maurer is currently accepting new patients.

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma. Dr. Ruiz is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Ruiz is currently accepting new patients.

Dr. Mayer is a pediatric hematologist-oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She specializes in the diagnosis and management of patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), Hodgkin lymphoma and non-Hodgkin lymphoma. She is also the medical director of the Vascular Anomalies and Birthmarks Program at the hospital. She cares for patients with benign and aggressive vascular tumors, lymphatic and venous malformations, and overgrowth syndromes. She was named the William A. Baumgartner Physician of the Year for Johns Hopkins All Children's in the 2024 Johns Hopkins Medicine Clinical Awards. She previously received the hospital’s Best Consulting Physician Award in 2017. Dr. Mayer is the author of more than 30 publications and two textbook chapters. She has presented over 22 research abstracts at national and international medical conferences. She is program director of a three-year fellowship training program in pediatric hematology-oncology on the St. Petersburg, Florida, campus. Dr. Mayer joined Johns Hopkins All Children’s in 1996. Dr. Mayer received her medical degree with honors from Dartmouth Medical School in New Hampshire. She completed her pediatric residency, hematology-oncology fellowship, and clinical research fellowship at Yale University School of Medicine in Connecticut. She is a fellow of the American Academy of Pediatrics and an active member and clinical researcher with Children’s Oncology Group, American Society of Pediatric Hematology-Oncology, and the International Society for the Study of Vascular Anomalies. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Evans Syndrome, Acute Monoblastic Leukemia (AmoL), and Teratoma of the Mediastinum. Dr. Mayer is board certified in American Board Of Pediatrics.

Dr. Booth specializes in bone marrow transplant as a hematologist-oncologist at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. She joined the hospital staff in 2023. She earned her medical degree at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Florida. She completed her residency at University of Florida, College of Medicine-Jacksonville and Wolfson Children’s Hospital in Jacksonville, Florida. She then completed a fellowship in pediatric hematology-oncology, followed by a fellowship in pediatric hematopoietic stem cell transplant, immunotherapy, at Phoenix Children’s Hospital and University of Arizona, College of Medicine-Phoenix. Her clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Infantile Neutropenia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant. Dr. Booth is board certified in American Board Of Pediatrics.

A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology. His clinical expertise encompasses Childhood Pancreatitis, RASopathies, Infantile Neutropenia, and Mast Cell Activation Syndrome (MCAS). Dr. Ritchey is board certified in American Board Of Pediatrics and American Board Of Pediatrics. Dr. Ritchey is currently accepting new patients.

Melinda Fritz is a Pediatric Hematologist Oncology provider practicing medicine in Summit, New Jersey. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Hemophilia A, and Hemophilic Arthropathy. Dr. Fritz is board certified in American Board Of Pediatrics. Dr. Fritz is currently accepting new patients.

Eric Kodish is a Pediatric Hematologist Oncology provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 44 years. His clinical expertise encompasses Newborn Jaundice, Immune Thrombocytopenic Purpura (ITP), Cardiofaciocutaneous Syndrome, and Colonoscopy. Dr. Kodish is board certified in American Board Of Pediatrics, 1994.

Nadia Cheek is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. Her clinical expertise encompasses Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hemoglobinopathy, and Congenital Hemolytic Anemia. Dr. Cheek is board certified in American Board Of Pediatrics.

Christopher Lawlor, MD, is an Atlantic Medical Group physician and the Division Chief of Pediatric Hematology and Oncology for the Valerie Fund Children’s Center. Board-certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics, and fellowship-trained in pediatric hematology and oncology, he specializes in blood disorders and cancers in children, adolescents, and young adults, treating children of all ages with benign and malignant disease.Dr. Lawlor has spent over 25 years dedicated to children and helping them overcome serious illness so that they can grow into healthy adults. Prior to coming to Atlantic Medical Group, he served as the medical director for Pediatric Specialists of Virginia Center for Cancer and Blood Disorders and was affiliated with prestigious Children’s National Hospital in the Washington, DC, area. In his accomplished career he has managed the unique needs of infants, children, adolescents, and young adults while employing the latest innovations and breakthroughs to help children with cancer and blood disorders. From diagnosis through recovery, Dr. Lawlor provides family- and child-centered care, ensuring that patients and families receive the supportive services necessary to help them through a critical illness. In addition, he is committed to long-term follow-up care, promoting ongoing health and wellness for pediatric cancer survivors. Dr. Lawlor has collaborated on research in pediatric cancer treatment, authored book chapters, and presented nationally and internationally on many aspects of pediatric hematology and oncology. He is a member of the Children’s Oncology Group and the Histiocyte Society.After earning his medical degree from New York Medical College, Dr. Lawlor completed both his residency and a fellowship in pediatric hematology and oncology at Children’s National Medical Center, Washington, DC, one of the top five children’s hospitals in the nation. He has been listed as a top doctor by the Washingtonian and Northern Virginia Magazine. Dr. Lawlor is a participating provider of the Atlantic Accountable Care Organization. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, Ewing Sarcoma, and Immune Thrombocytopenic Purpura (ITP). Dr. Lawlor is board certified in American Board Of Pediatrics. Dr. Lawlor is currently accepting new patients.

I enjoy reading and am mostly into reading children's books with my kids now. I love to be outdoors with them, swimming, hiking, or playing pretty much any sport. I also like to cook and of course, then eat. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Graft Versus Host Disease (GvHD), and Testicular Cancer. Dr. Truscott is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Truscott is currently accepting new patients.